Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows administrative revision updates including a new revision (v3.5.0) with recent update dates (2026-02-26, 2026-03-18). The previous revision history (v3.4.3) and its dates appear to have been removed.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this appears to be a minor system/UI update with no changes to study content, eligibility, or primary data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.4.1 is displayed, replacing v3.4.0; the page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedUI changes include a glossary toggle (Show glossary / Hide glossary) and minor metadata updates such as capitalization in labels like 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision noted as v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedMinor revision update from v3.3.3 to v3.3.4; no substantive changes to study content, eligibility criteria, or results were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.